| Glenn C Isaacson, MD | |
|
3509 N Broad St, Philadelphia, PA 19140 | |
| (215) 707-7300 | |
| (215) 707-6417 |
| Full Name | Glenn C Isaacson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 3509 N Broad St, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104814078 | NPI | - | NPPES |
| 0011396520001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD030568E (Pennsylvania) | Primary |
| Entity Name | Shriners Hospitals For Children |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1659615706 PECOS PAC ID: 9133031933 Enrollment ID: O20140508000878 |
News Archive
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute describes the biology behind why muscle stem cells respond differently to aging or injury.
Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Upon issuance, the patent will cover foundational induced pluripotent stem cell (iPSC) technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics.
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.
› Verified 7 days ago
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute describes the biology behind why muscle stem cells respond differently to aging or injury.
Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Upon issuance, the patent will cover foundational induced pluripotent stem cell (iPSC) technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics.
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glenn C Isaacson, MD 2450 W Hunting Park Ave, Philadelphia, PA 19129-1302 Ph: (215) 707-3663 | Glenn C Isaacson, MD 3509 N Broad St, Philadelphia, PA 19140 Ph: (215) 707-7300 |
News Archive
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute describes the biology behind why muscle stem cells respond differently to aging or injury.
Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Upon issuance, the patent will cover foundational induced pluripotent stem cell (iPSC) technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics.
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.
› Verified 7 days ago
Mark Rizzi, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104 Phone: 215-590-3440 Fax: 215-590-3986 | |
Rebecca Claire Chiffer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St Fl 6, Philadelphia, PA 19107 Phone: 215-955-6760 | |
Lukas David Dumberger, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-662-4613 | |
Dr. Marc R. Rosen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St, 6th Floor, Philadelphia, PA 19107 Phone: 215-955-6760 Fax: 215-923-4532 | |
Dr. Robert T Adelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 | |
Steven Bernard Cannady, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-829-5180 | |
Alexander G Chiu, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-614-0071 |